135 related articles for article (PubMed ID: 32007665)
1. Immunosuppressive properties of amino acid and peptide derivatives of mycophenolic acid.
Siebert A; Cholewiński G; Trzonkowski P; Rachon J
Eur J Med Chem; 2020 Mar; 189():112091. PubMed ID: 32007665
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid.
Siebert A; Deptuła M; Cichorek M; Ronowska A; Cholewiński G; Rachon J
Anticancer Agents Med Chem; 2021; 21(4):462-467. PubMed ID: 32416705
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of ester derivatives of mycophenolic acid and acridines/acridones as potential immunosuppressive agents.
Cholewinski G; Iwaszkiewicz-Grzes D; Trzonkowski P; Dzierzbicka K
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):974-82. PubMed ID: 26308114
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of mycophenolic acid-amino acid derivatives.
Iwaszkiewicz-Grzes D; Cholewinski G; Kot-Wasik A; Trzonkowski P; Dzierzbicka K
Eur J Med Chem; 2013 Nov; 69():863-71. PubMed ID: 24121309
[TBL] [Abstract][Full Text] [Related]
5. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
6. Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents.
Walczak JM; Iwaszkiewicz-Grześ D; Ziomkowska M; Śliwka-Kaszyńska M; Daśko M; Trzonkowski P; Cholewiński G
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2725-2741. PubMed ID: 36189734
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus
Zhang Q; Yang B; Li F; Liu M; Lin S; Wang J; Xue Y; Zhu H; Sun W; Hu Z; Zhang Y
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 29986508
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives.
Malachowska-Ugarte M; Cholewinski G; Dzierzbicka K; Trzonkowski P
Eur J Med Chem; 2012 Aug; 54():197-201. PubMed ID: 22621840
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of new mycophenolic acid conjugates with adenosine derivatives.
Prejs M; Cholewiński G; Trzonkowski P; Kot-Wasik A; Dzierzbicka K
J Asian Nat Prod Res; 2019 Feb; 21(2):178-185. PubMed ID: 29607657
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.
Sunohara K; Mitsuhashi S; Shigetomi K; Ubukata M
Bioorg Med Chem Lett; 2013 Sep; 23(18):5140-4. PubMed ID: 23937979
[TBL] [Abstract][Full Text] [Related]
13. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
[TBL] [Abstract][Full Text] [Related]
14. Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):972-977. PubMed ID: 29792360
[TBL] [Abstract][Full Text] [Related]
15. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
[TBL] [Abstract][Full Text] [Related]
16. New Analogues of Mycophenolic Acid.
Siebert A; Prejs M; Cholewinski G; Dzierzbicka K
Mini Rev Med Chem; 2017; 17(9):734-745. PubMed ID: 27903231
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid analogs with a modified metabolic profile.
Chen L; Wilson DJ; Labello NP; Jayaram HN; Pankiewicz KW
Bioorg Med Chem; 2008 Oct; 16(20):9340-5. PubMed ID: 18809333
[TBL] [Abstract][Full Text] [Related]
18. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
[TBL] [Abstract][Full Text] [Related]
19. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
[TBL] [Abstract][Full Text] [Related]
20. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Clin Chem; 1997 Dec; 43(12):2312-7. PubMed ID: 9439448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
